Related Experiment Video

Updated: Jul 26, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Gram-Positive Pneumonia

Osiyemi1, Dickinson

  • 1Medical Service Miami Veterans Affairs Medical Center and University of Miami School of Medicine, 1201 N.W. 16th Street, Miami, FL 33125, USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed

Insights

Gram-positive pneumonia, caused by bacteria like Streptococcus pneumoniae and Staphylococcus aureus, presents diagnostic and drug resistance challenges. Control strategies focus on vaccines and infection control measures.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Gram-positive pneumonia is a significant global cause of illness and death.
  • Streptococcus pneumoniae and Staphylococcus aureus are the most frequent bacterial culprits.
  • Current diagnostic methods for gram-positive pneumonia are inadequate.

Purpose of the Study:

  • To review the challenges in diagnosing and treating gram-positive pneumonia.
  • To discuss the growing problem of antimicrobial resistance in gram-positive pathogens.
  • To outline current and future strategies for controlling resistant strains.

Main Methods:

  • Literature review of diagnostic techniques for gram-positive pneumonia.
  • Analysis of antimicrobial resistance patterns for Streptococcus pneumoniae and Staphylococcus aureus.
  • Evaluation of control strategies including vaccines and infection policies.

Main Results:

  • Newer diagnostic tests like antigen detection show limited proven efficacy.
  • Antimicrobial resistance among gram-positive organisms is widespread and poses a therapeutic challenge.
  • Effective control measures are crucial for managing resistant strains.

Conclusions:

  • Improved diagnostic tools are needed for gram-positive pneumonia.
  • Combating antimicrobial resistance requires multifaceted approaches.
  • Vaccination and stringent infection control are key to managing gram-positive bacterial infections.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...